The neurofilament derived-peptide NFL-TBS.40-63 enters in-vitro in human neural stem cells and increases their differentiation - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue PLoS ONE Année : 2018

The neurofilament derived-peptide NFL-TBS.40-63 enters in-vitro in human neural stem cells and increases their differentiation

(1) , (2) , (1)
1
2

Résumé

Regenerative medicine is a promising approach to treat neurodegenerative diseases by replacing degenerating cells like neurons or oligodendrocytes. Targeting human neural stem cells directly in the brain is a big challenge in such a strategy. The neurofilament derived NFL-TBS.40-63 peptide has recently been introduced as a novel tool to target neural stem cells. Previous studies showed that this peptide can be internalized by rat neural stem cells in vitro and in vivo, which coincided with lower proliferation and self-renewal capacity and increase of differentiation. In this study, we analyzed the uptake and potential effects of the NFL-TBS.40-63 peptide on human neural stem cells isolated from human fetuses. We showed that the peptide inhibits proliferation and the ability to produce neurospheres in vitro, which is consistent with an increase in cell adhesion and differentiation. These results confirm that the peptide could be a promising molecule to target and manipulate human neural stem cells and thus could serve as a strategic tool for regenerative medicine.

Fichier principal
Vignette du fichier
barreau_2018_the_neurofilament_derivated-peptide_nlf.pdf (8.86 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

hal-02616046 , version 1 (24-05-2020)

Identifiants

Citer

Kristell Barreau, Claudia Montero-Menei, Joël Eyer. The neurofilament derived-peptide NFL-TBS.40-63 enters in-vitro in human neural stem cells and increases their differentiation. PLoS ONE, 2018, 13 (8), pp.e0201578. ⟨10.1371/journal.pone.0201578⟩. ⟨hal-02616046⟩
21 Consultations
48 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More